FDA OKs first seasonal flu vaccine made using animal cell cultures

11/20/2012 | Reuters

The FDA has approved the use of Novartis' seasonal influenza vaccine for people ages 18 and older. The vaccine, which will be marketed under the brand name Flucelvax, is the first seasonal flu vaccine produced using animal cell cultures instead of the traditional chicken egg method, which allows for a faster production process.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Content Design Manager, Science
NWEA
Multiple Locations, SL_Multiple Locations
Sr. Technical Product Manager
NWEA
Portland, OR
Program Officer, Teacher Development
Knowles Science Teaching Foundation
Moorestown, NJ
Production Manager, Education and Leadership
Asia Society
New York, NY
CONTRACT - Education Consultants
Confidential
East Coast, Phoenix, Los Angeles, SL_Multiple Locations